Sleep hormone trial offers hope for ICU confusion
NCT ID NCT05713877
Summary
This small study is testing whether melatonin, a natural sleep hormone, can help reduce the duration of delirium in critically ill patients in intensive care. Researchers want to see if it's practical to run a larger future trial by measuring how many patients they can enroll and whether patients can take the medication as scheduled. The study will also track whether melatonin shortens delirium episodes compared to a placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DELIRIUM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hopital Maisonneuve-Rosemont
RECRUITINGMontreal, Quebec, H1T 2M4, Canada
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.